Bio-path Holdings, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
OTC.Pink
Bio-Path Holdings is seeking stockholder approval for several key proposals at its upcoming annual meeting, including the election of directors, ratification of auditors, an amendment to the stock incentive plan, a reverse stock split, and approval for the issuance of more than 20% of common stock pursuant to a private placement.
OTC.Pink
Bio-Path Holdings is convening its 2024 Annual Meeting of Stockholders to vote on key proposals including a reverse stock split, an amendment to the stock incentive plan, and the approval of recent equity issuances.